Loss of NF1 activates RAS-MEK signalling, which in turn represses ZNF423, a critical transcriptional coactivator of the retinoic acid receptors; neuroblastomas with low levels of both NF1 and ZNF423 have an extremely poor outcome. Here, NF1 is linked to neuroblastoma.